Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma

NCT00276055 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Gemcitabine, Docetaxel and Bevacizumab

Sponsor

New Mexico Cancer Research Alliance